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Abstract The purpose of this work was to analyze
chemokine and chemokine receptor expression in untreated
and in irradiated squamous cell carcinoma of the head and
neck (SCCHN) tumor cell lines, aiming at the establish-
ment of assays to test for the relevance of chemokine and
chemokine receptor expression in the response of SCCHN
to radiotherapy and radiochemotherapy. Five low passage
and 10 established SCCHN lines, as well as two normal cell
lines, were irradiated at 2 Gy or sham-irradiated, and har-
vested between 1 and 48 h after treatment. For chemokines
with CC and CXC structural motifs and their receptors,
transcript levels of target and reference genes were quanti-
Wed relatively by real-time PCR. In addition, CXCL1
and CXCL12 protein expression was analyzed by ELISA.
A substantial variation in chemokine and chemokine receptor
expression between SCCHN was detected. Practically, all
cell lines expressed CCL5 and CCL20, while CCL2 was
expressed in normal cells and in some of the tumor cell
lines. CXCL1, CXCL2, CXCL3, CXCL10, and CXCL11
were expressed in the vast majority of the cell lines, while
the expression of CXCL9 and CXCL12 was restricted to
Wbroblasts and few tumor cell lines. None of the analyzed
cell lines expressed the chemokines CCL3, CCL4, or
CCL19. Of the receptors, transcript expression of CCR1,
CCR2, CCR3, CCR5, CCR7, CCXR2, and CCXR3 was not
detected, and CCR6, CXCR1, and CXCR4 expression was
restricted to few tumor cells. Radiation caused up- and
down-regulation with respect to chemokine expressions,
while for chemokine receptor expressions down-regula-
tions were prevailing. CXCL1 and CXCL12 protein expres-
sion corresponded well with the mRNA expression. We
conclude that the substantial variation in chemokine and
chemokine receptor expression between SCCHN oVer
opportunities for the establishment of assays to test for the
relevance of chemokine and chemokine receptor expression
in the response of SCCHN to radiotherapy and radiochemo-
therapy.
Introduction
Tumors are embedded in a rich cell microenvironment,
which is essential for tumor cell survival, cancer progres-
sion, and metastasis. However, the means by which tumor
cells interact with their surrounding are mostly unknown.
Chemokine molecules constitute a superfamily of often
inducible, secreted, proinXammatory proteins involved in a
variety of immune responses, acting primarily as chemo-
attractants and activators of speciWc types of leukocytes.
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They are typically induced by inXammatory cytokines,
growth factors, and pathogenic stimuli and signal through
transmembrane G-protein-coupled (chemokine) receptors.
Chemokines are made and secreted by many diVerent cell
types, including tumor cells, tumor stroma cells, and tumor-
inWltrating immune cells (Zlotnik 2006). Recent studies have
shown the involvement of chemokine signaling in cancer
treatment response and metastasis through autocrine and par-
acrine mechanisms (Wang et al. 2009; Zlotnik 2006).
Radiotherapy is an established treatment option for
numerous tumors, and evidence is accumulating that radia-
tion has considerable eVects on chemokine expression (Ao
et al. 2009; Facoetti et al. 2009; Gremy et al. 2008; John-
ston et al. 2002; im et al. 2009; Kuhlmann et al. 2009;
Linard et al. 2004; Lugade et al. 2008; Matsumura et al.
2008; Mihaescu et al. 2010; Moriconi et al. 2008; Muller
and Meineke 2007; Sanzari et al. 2009; Schmidtner et al.
2009), while radiation eVects on chemokine receptor
expression are poorly investigated (Johnston et al. 2002;
Malik et al. 2010). Experimental studies analyzed normal
cells (Facoetti et al. 2009; Kuhlmann et al. 2009; Moriconi
et al. 2008; Muller and Meineke 2007) or tissues (Ao et al.
2009; Gremy et al. 2008; Johnston et al. 2002; Linard et al.
2004; Malik et al. 2010; Mihaescu et al. 2010; Moriconi
et al. 2008), as well as tumor cells of diVerent origin (Kim
et al.  2009; Lugade et al. 2008; Matsumura et al. 2008;
Sanzari et al. 2009; Schmidtner et al. 2009).
Squamous cell carcinoma of the head and neck
(SCCHN) has been shown to express a number of chemo-
kines, and their receptors, which may e.g., promote chemo-
therapy resistance (Muller et al. 2006; Wang et al. 2008) or
may allow them to access the lymphatic system and spread
to regional lymph nodes (Samara et al. 2004; Ueda et al.
2009; Wang et al. 2004,  2005a,  b). Schmidtner et al.
reported on radiation-associated escalation of the chemo-
kine CCL22 in SCCHN tumor cell supernatants, which
might modify the transmigration of tumor-inWltrating lym-
phocytes beneWcially and thereby support the immune
response (Schmidtner et al. 2009).
We are aiming at the establishment of assays to test for
the relevance of chemokine and chemokine receptor
expression in the response of SCCHN to radiotherapy and
radiochemotherapy. While searching the literature, we
found that there are practically no published data on che-
mokine and chemokine receptor expression in commer-
cially available SCCHN tumor cell lines. Therefore, we
analyzed the transcript expression of 24 genes (Table 1),
involving chemokines and chemokine receptors in 15
SCCHN and 2 normal cell lines; for validation, extracts
pooled from cells with known or putative chemokine and
chemokine receptor expression were analyzed as well.
The analyzed genes were selected with respect to our
experiences concerning radiation-dependent cytokine/che-
mokine regulation (Malik et al. 2010; Moriconi et al. 2008)
and with respect to published reports on chemokine expres-
sion in head and neck cancer (Abiko et al. 2003; Almofti
et al.  2004; Chakraborty et al. 2008; Chang et al. 2008;
Delilbasi et al. 2004; Ferreira et al. 2008; Ishikawa et al.
2006; Khademi et al. 2008; Michiels et al. 2009; Miyazaki
et al. 2006; Muller et al. 2006; Oliveira-Neto et al. 2008;
Rehman and Wang 2008; Takes et al. 2008; Tan et al.
2008; Tsuzuki et al. 2006; Ueda et al. 2009; Wang et al.
2005, 2008; Wen et al. 2008; Yeudall and Miyazaki 2007).
Materials and methods
The SCCHN cell lines used were either established from
tumor material and used at low passage numbers (Rave-Frank
et al. 1996) or commercially available (established cell lines)
Table 1 Chemokines and 
chemokine receptors of which 
the transcript expression was 
analyzed
Chemokine Other names Full name Receptor
CCL2 MCP-1, SCYA-2 Monocyte chemoattractant protein 1 CCR2
CCL3 MIP-1, SCYA3 Macrophage inXammatory protein 1 alpha CCR1, 5
CCL4 MIP-1, SCYA4 Macrophage inXammatory protein 1 beta CCR5, 8
CCL5 RANTES Regulated upon activation of normal T cell CCR1, 3, 5
CCL19 MIP3-, SCYA19 Macrophage inXammatory protein 3 beta CCR7
CCL20 MIP3-, LARC Macrophage inXammatory protein 3 alpha CCR6
CXCL1 GRO, SCYB1 Growth-related oncogene alpha CXCR1, 2
CXCL2 GRO, SCYB2 Growth-related oncogene beta CXCR1, 2
CXCL3 GRO, SCYB3 Growth-related oncogene gamma CXCR1, 2
CXCL9 MIG, SCYB9 Monokine induced by interferon gamma CXCR3
CXCL10 IP-10, SCYB10 Interferon-inducible protein-10 kilodaltons CXCR3
CXCL11 I-TAC, SCYB9B Interferon-inducible T-cell alpha chemoattractant CXCR3
CXCL12 SDF-1, SCYB12 Stromal cell-derived factor 1 CXCR4Radiat Environ Biophys (2011) 50:145–154 147
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(Table 2). For experiments, cells were grown in their
recommended media (Table 2), irradiated at 2 Gy or sham-
irradiated, and harvested 6, 24, or 48 h upon treatment. Cell
pellets and cell supernatants were stored at ¡80°C. For
real-time PCR, cells were washed in PBS and stored at
¡80°C in lysis buVer contained in RNeasy mini kit
(Qiagen, Hilden, Germany). Total cell amount per sample
was about 1 million cells. RNA was isolated using Rneasy
mini kit according to the manufacturer’s instructions. The
amount of RNA was meticulously quantiWed by a spectro-
photometric method speciWcally designed for precise mea-
surements of undiluted samples in low microliter scale
(LabelGuard cuvette; Implen, Munich, Germany). Reverse
transcription to complementary DNA was eVected for 1 h
with 1 g total RNA using Super-Script II reverse trans-
criptase (Invitrogen, Carlsbad, California, USA) and 20
units per sample recombinant RNase inhibitor (USB, Cleve-
land, Ohio, USA). Transcript numbers of target and reference
genes were quantiWed relatively by real-time PCR using
HotStart-IT SYBR Green qPCR-Master Mix (USB, Cleve-
land, Ohio, USA) in a real-time PCR machine (HT7900,
Applied Biosystems, Foster City, California, USA). PCR
conditions were 40–50 cycles (dependent on expression
level) with annealing at 60°C for 20 s and elongation at
72°C for 40 s for each primer pair. SpeciWc primer pairs
were synthesized by MWG, Ebersberg, Germany. EYcacy
and speciWcity of primers were tested by serial dilution
(factor 625). Primer sequences are given in Table 3. Data
were normalized to weighted mean expression of HPRT1
and UBC serving as reference genes. The analysis was per-
formed for cells harvested 6 h after treatment and sham-
treated cells, respectively. Greater than twofold changes in
transcript expression were taken as signiWcant.
The amount of CXCL1 or CXCL12 protein was deter-
mined in cell culture supernatants by the Quantikine®
Human CXCL1 or CXCL12 Immunoassays, R&D Systems,
Minneapolis, USA, according to recommended protocols.
For experiments, tumor cells, HaCat-keratinocytes, or
Wbroblasts (1,000.000 cells/Xask) were seeded in 25-cm2
Xasks (Nalge Nunc Int., Rochester, NY) in their speciWc
medium and allowed to attach. For measurement, superna-
tants collected either 0 h (control), 6, 24, or 48 h after
(sham-)irradiation, and particulates were removed by
centrifugation. Measurements were repeated 3 times, and
the statistical signiWcance of increased chemokine concen-
trations was tested by ANOVA.
Table 2 Origin and names of the used cell lines
a Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany
b Deutsches Krebsforschungszentrum, Heidelberg, Germany
c Health Science Research Resources Bank, Japan Health Sciences Foundation, Japan
d Department of Radiation Oncology, OncoRay-Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, Technische Uni-
versität Dresden, Germany
e Universitätsmedizin Göttingen, Department of Radiotherapy and Radiation Oncology, Göttingen, Germany
f Lymphnode metatasis
Cell line Obtained from Medium Origin
BHY DSMZa DMEM SCC (lower alveolus)
XF 354 DKFZb DMEM SCC (oral, Mf)
CAL33 DSMZa DMEM SCC (tongue)
SAS HSRRBc DMEM + HAMsF12 1:1 SCC (tongue)
CAL 27 DSMZa DMEM SCC (tongue)
HSC4 HSRRBc MEM SCC (tongue)
HO 1u1 HSRRBc DMEM + HAMsF12 1:1 SCC (mouth Xoor)
SKN3 HSRRBc RPMI SCC (oral cavity)
KOSC2 HSRRBc RPMI SSC (oral Xoor)
FaDu RT-Dresdend DMEM SCC (pharyngeal)
ZMK-1 RT-Göttingene DMEM + HAMsF12 1:1 SCC (Oropharynx)
BW-225 RT-Göttingene DMEM + HAMsF12 1:1 SCC (Oropharynx)
HK-147 RT-Göttingene DMEM + HAMsF12 1:1 SCC (Oropharynx)
GR-145-I RT-Göttingene DMEM + HAMsF12 1:1 SCC (Oropharynx)
GR-145-II RT-Göttingene DMEM + HAMsF12 1:1 SCC (Oropharynx)
DF-19 RT-Göttingene DMEM Dermal Wbroblasts
HaCat DKFZb DMEM Epidermal keratinocytes148 Radiat Environ Biophys (2011) 50:145–154
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Results
Within the pooled validation samples consisting of extracts
from human lymphocytes, colorectal, and hepatocellular
cancer cells, signiWcant transcript expression of all ana-
lyzed chemokines and chemokine receptors was detected;
the respective CT-values are given in Table 4.
Normal cells, as represented by dermal Wbroblasts and
HaCat-keratinocytes, showed comparable expression pat-
terns, namely the expression of a variety of chemokines and
no chemokine receptors. The transcript expression data for
normal cells are integrated in Figs. 1, 2, 3, 4.
Practically, all cell lines expressed the CC-chemokines
CCL5 and CCL20, while CCL2 was expressed in normal
cells and in some of the tumor cell lines (BHY, CAL27,
CAL33, HSC4, SAS, BW-225, ZMK-1) (Fig. 1a–c). Like-
wise, the CXC-chemokines CXCL1, CXCL2, CXCL3,
CXCL10, and CXCL11 were expressed in the vast majority
of the cell lines, while the expression of CXCL9 and
CXCL12 was restricted to Wbroblasts and the tumor cell
lines CAL27, CAL33, XF354, BW-225, and GR-145-I/II,
HK-147, BW-225, respectively. Data representing tran-
script expressions of CXCL1, 2, 3 are given in Fig. 2 a–c;
data representing transcript expressions of CXCL10, 11, 9,
12 are given in Fig. 3 a–d. None of the analyzed cell lines
expressed the chemokines CCL3, CCL4, and CCL19.
Of the receptors, transcript expression of CCR1, CCR2,
CCR3, CCR5, CCR7, CCXR2, CCXR3 was not detected,
and CCR6 expression was restricted to BHY, KOSC2,
SKN3, GR-145-I, and HK-147 tumor cells (Fig. 4a). The
CXC-chemokine receptors were expressed in diVerent cell
lines; CXCR1 was expressed in HaCat, CAL33, HSC4, and
XF354 (Fig. 4b), and CXCR4 was expressed in HO 1u1,
FaDu, BW-225, and ZMK-1 (Fig. 4c). Radiation caused
up- and down-regulation with respect to chemokine expres-
sions, while for chemokine receptor expressions down-reg-
ulations were prevailing. Greater than twofold radiation-related
changes were regarded as signiWcant and are marked by
asterisks in the respective Wgures.
To test whether mRNA transcript expression was trans-
lated into protein, the presence of CXCL1 and CXCL12
was determined in cell culture supernatants by ELISA.
Figure 5a, b show that the protein expression matches the
mRNA transcript data well; however, no signiWcant diVer-
ences between irradiated and sham-irradiated cells were
detected. Furthermore, Fig. 6 demonstrates that CXCL12
accumulates in irradiated cell culture supernatants over
time, the increase being signiWcant for tumor (BW-225) and
normal (DF-19) cells.
Table 4 Transcript expression of chemokines and chemokine recep-
tors in the pooled sample
Chemokine CT Chemokine receptor CT
CCL2 20,33 CCR1 30,80
CCL3 26,08 CCR2 29,07
CCL4 29,67 CCR3 28,58
CCL5 26,43 CCR5 29,44
CCL19 30,15 CCR6 22,77
CCL20 18,07 CCR7 30,12
CXCL1 19,06 CCR8 29,44
CXCL2 19,89 CXCR1 29,85
CXCL3 20,58 CXCR2 31,79
CXCL9 29,66 CXCR3 27,18
CXCL10 26,91 CXCR4 24,84
CXCL11 25,99
CXCL12 30,03
Fig. 1 CC-chemokine transcript expression relative to housekeeping genes in tumor and normal cell lines; a CCL5, b CCL20, c CCL2. Greater
than twofold expression changes were regarded as signiWcant and are marked by asterisks150 Radiat Environ Biophys (2011) 50:145–154
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Discussion
Aim of the present study was the analysis of chemokine and
chemokine receptor expression in SCCHN tumor cell lines;
for comparison, expressions in cell lines representing nor-
mal tissue were tested as well. All tumor cell lines represent
squamous cell carcinoma (SSC), and all but one were
derived from primary tumors. The only exception, XF 354
cells, stem from a lymph node metastasis of an oral SCC.
Wang et al. showed a consistent pattern of CCR6 down-
regulation and up-regulation of CCR7 in metastatic
SCCHN cells (Wang et al. 2005a); however, in the present
study, neither CCR6 nor CCR7 expression was detected in
XF 354 cells. This result is comparable to a study by Muller
et al., reporting no diVerence in the expression of chemo-
kine receptors in primary SCCHN and corresponding
lymph node metastases (Muller et al. 2006).
In general, in the analyzed cell lines, the expression of
chemokines was more common than the expression of che-
mokine receptors. The pronounced chemokine expression
by the tumor cell lines may indicate that they reliably mir-
ror the inXammatory microenvironment of tumors,
although cultured cancer cells can exhibit distinct proper-
ties compared with their naturally growing counterparts.
For SCCHN, the (over)-expression and secretion of the
CC-chemokines CCL2, CCL5, and CCL20, which were
identiWed in the cell lines of the present study, have repeat-
edly been described (Abiko et al. 2003; Buettner et al.
2007; Chang et al. 2008; Ferreira et al. 2008; Michiels et al.
2009). The same applies to the expression of the CXC-
chemokines, whereupon the homogeneous expression of
CXC1-3 is explainable, as they cluster in a narrow region
of chromosome 4 and are often coexpressed (Bieche et al.
2007). For SCCHN, CXC-chemokines have been suggested
as useful as biomarkers for response and survival in
patients with locally advanced oropharyngeal and head and
neck SCC treated with radiochemotherapy (Allen et al.
2007).
Of the CXC receptors, only CXCR1 and CXCR4 expres-
sion was detected in the analyzed tumor cell lines. Uchida
et al. reported on comparable Wndings using lymph node
metastatic (HNt and B88) and non-metastatic oral SCC
cells, where of 13 kinds of chemokine receptors examined,
only CXCR4 expression was up-regulated (Uchida et al.
2003). Several studies have already documented the impor-
tance of CXCR4 in SCCHN tumor progression and organ-
speciWc metastasis (Almofti et al. 2004; Delilbasi et al.
2004; Ishikawa et al. 2006; Oliveira-Neto et al. 2008;
Rehman and Wang 2008; Tan et al. 2008) and that a high
level of CXCR4 could be used as a prognostic factor (Wang
et al. 2005c). Furthermore, it was suggested that in cases of
oral SCC, the paracrine CXC12/CXCR4 system potentiates
lymph node metastasis, but distant metastasis might require
the autocrine CXC12/CXCR4 system (Uchida et al. 2007).
Interestingly, of the tumor cell lines expressing CXCR4 in
the present study, three (HO 1u1, FaDu, ZMK-1) expressed
CXCR4 only, and one expressed CXCR4 and its ligand
CXC12. The diVerential expression may render them possi-
ble candidates for cell migration and invasion studies after
radiation or radiation and drug treatment.
For irradiation, the common clinical single dose of 2 Gy
was used, as irradiation at therapeutic doses can induce
essential molecular signals required for an eVective
response of the immune system to the tumor (Demaria and
Formenti 2007). Even extremely low-dose ionizing radia-
tion (1 cGy) caused an up-regulation of three CXC-chemo-
kines (CXCL1, CXCL2, and CXCL6) in human Wbroblasts
(Fujimori et al. 2005). In the present study, the normal cells
Fig. 2 CXC-chemokine transcript expression relative to housekeeping genes in tumor and normal cell lines; a CXCL1, b CXCL2, c CXCL3.
Greater than twofold expression changes were regarded as signiWcant and are marked by asterisksRadiat Environ Biophys (2011) 50:145–154 151
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Fig. 3 CXC-chemokine tran-
script expression relative to 
housekeeping genes in tumor 
and normal cell lines; 
a CXCL10, b CXCL11, 
c CXCL9, d CXCL12. Greater 
than twofold expression changes 
were regarded as signiWcant and 
are marked by asterisks
Fig. 4 Chemokine receptor transcript expression relative to housekeeping genes in tumor and normal cell lines; a CCR6, b CXCR1, c CXCR4.
Greater than twofold expression changes were regarded as signiWcant and are marked by asterisks152 Radiat Environ Biophys (2011) 50:145–154
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(Wbroblasts; HaCat) also showed a radiation-induced
up-regulation of CXCL1, CXCL2, and CXCL3, which was
always greater than twofold in HaCat cells and greater than
twofold for CXCL3 in Wbroblasts. We could conWrm the
CXCL1 expression on the protein level; however, diVer-
ences between irradiated and non-irradiated cells were mar-
ginal. With respect to the CXCL3 mRNA transcript
expression, we observed a marked diVerence between nor-
mal and tumor cells; while both normal cell lines showed
the above-mentioned radiation-induced up-regulation, a
down-regulation was observed all tumor cell lines.
For further chemokines, e.g., the CC-chemokines CCL2
and CCL5, or the CXC-chemokine CXCL12, transcript
expressions were modiWed after irradiation. It might be
worth to test the possibility that chemokines could be used
as biomarkers of radiation responses. For mice, it has
already been shown that radiation induces earlier and
greater temporal changes in multiple cytokines and chemo-
kines in pulmonary Wbrosis-sensitive compared to Wbrosis-
resistant animals (Ao et al. 2009). Herein, we could show
persistent expression and signiWcant accumulation of
CXCL12 protein in cell culture supernatants of irradiated
tumor cells and Wbroblasts.
Our study has several limitations. Although a wide
panel of cell lines was used, the reported results cannot
be generalized but apply solely to the cell lines of the
present study. The transcript expressions reported herein
and the detection of CXCL1 and CXCL12 proteins in cell
culture supernatants are strong indicators of chemokine
and chemokine receptor expressions, but will need conWr-
mation by further protein analysis and functional assays in
future.
In conclusion, the substantial variation in chemokine and
chemokine receptor expression between SCCHN oVer
opportunities for the establishment of assays to test for the
relevance of chemokine and chemokine receptor expression
in the response of SCCHN to radiotherapy and radiochemo-
therapy.
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